ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,318.40
      0.11%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      73.955
      0.09%
      Bitcoin
      63,608.00
      -0.02%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Evofem Biosciences Inc (EVFM) Quote

      Evofem Biosciences Inc

      Evofem Biosciences Inc (EVFM)

      Evofem Biosciences Inc (QB)
      0.4782
      0.00
      (0.00%)
      Closed September 20 4:00PM
      Delayed by 15 minutes
      0.4782
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.4782
      Bid
      0.465
      Ask
      0.468
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      2.716M
      Previous Close
      0.4782
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      5,680,000
      Dividend Yield
      -
      PE Ratio
      0.11
      Earnings Per Share (EPS)
      8.8
      Revenue
      18.22M
      Net Profit
      50M

      About Evofem Biosciences Inc

      Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmi... Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.evofem.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      EVFM Latest News

      More News

      Biopharma Partners with Telemed Firm and Shares are Climbing

      This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership To...

      June 27 2024
      AllPennyStocks.com

      Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

      Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire SAN DIEGO, June 1, 2023 Increased net product revenue more than 35% in the first quarter of 2023...

      June 01 2023
      PR Newswire (US)

      Evofem Biosciences Announces 1-for-125 Reverse Stock Split

      Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire SAN DIEGO, May 17, 2023 -- CUSIP number for Evofem will change to 30048L302 on May 18, 2023 -- -- Ticker symbol will change...

      May 17 2023
      PR Newswire (US)

      Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

      Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required PR Newswire SAN DIEGO, April 12, 2023 — Improves Phexxi coverage for more than 5.8 million New York...

      April 12 2023
      PR Newswire (US)

      Evofem Biosciences Announces Cost Reduction Measures

      Evofem Biosciences Announces Cost Reduction Measures PR Newswire SAN DIEGO, March 21, 2023 – Company cuts management pay and lowers headcount to decrease operating costs – – Reductions align with...

      March 21 2023
      PR Newswire (US)

      Evofem Biosciences Appoints Interim Chief Financial Officer

      Evofem Biosciences Appoints Interim Chief Financial Officer PR Newswire SAN DIEGO, March 9, 2023 SAN DIEGO, March 9, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to...

      March 09 2023
      PR Newswire (US)

      Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering

      Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering PR Newswire SAN DIEGO, Feb. 28, 2023 -- Phexxi is the first and only hormone-free contraceptive offered by reproductive...

      February 28 2023
      PR Newswire (US)

      Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

      Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi PR Newswire SAN DIEGO, Feb. 27, 2023 -- Evofem now has four Orange Book listed patents covering...

      February 27 2023
      PR Newswire (US)

      Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value

      Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value PR Newswire SAN DIEGO, Feb. 23, 2023 SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB:...

      February 23 2023
      PR Newswire (US)

      Costco Adds Phexxi® to Member Prescription Program

      Costco Adds Phexxi® to Member Prescription Program PR Newswire SAN DIEGO, Jan. 10, 2023 SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that...

      January 10 2023
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NUKKNukkleus Inc
      $ 0.3604
      (69.60%)
      		13.79M
      SOXMTradr 2X Long SOXX Monthly ETF
      $ 36.96
      (58.98%)
      		44
      LGCBLinkage Global Inc
      $ 0.6354
      (51.90%)
      		9.32M
      NVVENuvve Holding Corporation
      $ 5.62
      (43.37%)
      		732.37k
      LGHLWLion Group Holding Ltd
      $ 0.008
      (33.33%)
      		12
      PRFXPainReform Ltd
      $ 0.59
      (-23.49%)
      		15.68k
      ZJYLJin Medical International Ltd
      $ 3.20
      (-21.57%)
      		21.54k
      SMXTSolarMax Technology Inc
      $ 0.7029
      (-19.75%)
      		200
      ADTXAditxt Inc
      $ 0.3101
      (-18.95%)
      		58.13k
      CJETChijet Motor Company Inc
      $ 2.28
      (-18.57%)
      		750
      NUKKNukkleus Inc
      $ 0.3604
      (69.60%)
      		13.79M
      LGCBLinkage Global Inc
      $ 0.6472
      (54.72%)
      		9.32M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.0776
      (-15.19%)
      		3.23M
      GSIWGarden Stage Ltd
      $ 1.63
      (21.64%)
      		2.99M
      INTCIntel Corporation
      $ 22.61
      (3.53%)
      		1.76M

      Discussion

      View Full Feed
      Jrod301 Jrod301 1 minute ago
      More likely another Pump and Dump, with more broken promises. Never trust a Hen!!!!! FKH.
      GMER
      WojD40 WojD40 2 minutes ago
      The villain you're looking for is Novocure. Shady science and shady people doing shady things. Like insider selling on a huge scale, and no doubt a budget for abusing a company which will eventually put you out of business. It's no more complicated than that. The NWBO shorts are representatives of N
      NVCR NWBO
      TrendTrade2016 TrendTrade2016 3 minutes ago
      ALZHEIMERS CANNOT AND WILL NOT EVER BE CURED...ITS A DIET RELATED DISEASE SO DO NOT LISTEN TO THE CLOW SHOW!
      CLOW
      sctts sctts 7 minutes ago
      $$$ Today is the Day $$$$

      $$$$ $frx $$$$
      FRX
      TrendTrade2016 TrendTrade2016 8 minutes ago
      CLOWNS CALLING A DOLLA...THE CLOWN SHOW HAS ENDED..LISTENING TO THESE CLOWS AND U WILL BE HOLDING A HEAVIER BAG THEN YOU ALREADY ARE...WATCH AND LEARN
      TGRP
      SCAMBUSTERKING SCAMBUSTERKING 9 minutes ago
      Jake will do anything but play by the rules. Can't apply and get access to OTCIQ and get that done? Wonder why... 😘
      BCAP
      TIMGZ TIMGZ 11 minutes ago
      THAT IS VERY FAST, IN AND OUT****WHAT IS THE SHARE COUNT YOU USUALLY PULL
      chicks0123 chicks0123 13 minutes ago
      Good morning CLNVERS
      CLNV
      Methinks Methinks 16 minutes ago
      https://www.businesswire.com/news/home/20240923435813/en/Security-Debt-in-EMEA-Escalates-Amid-Rising-Cyber-Threat-Veracode-Report-Reveals-Urgent-Need-for-AI-Powered-Remediation-and-Application-Security-Posture-Management
      Use Wave to reduce costs.
      rocketeer357 rocketeer357 17 minutes ago
      Better hope the Mets take the opener in Atlanta. A 3 game cushion with 5 to play should do it. Lose the first one and the screws tighten up considerably, even though the players try and pretend otherwise.
      Methinks Methinks 18 minutes ago
      https://www.lawsociety.ie/gazette/top-stories/2024/september/lunchtime-webinar-on-reducing-cyber-risks
      Will they include Wave?
      rocketeer357 rocketeer357 20 minutes ago
      He's been serving up a lot of meatballs. Not sure how the crew will work the starting pitching in the playoffs, but there's not a single starter on the team with enough of a pedigree to warrant even a short leash.

      Freddy starts game 1. If he can go 6, that's a great outing for him. G
      Methinks Methinks 20 minutes ago
      https://www.emergingrisks.co.uk/dark-web-cyber-threat-is-real-report/
      Look and learn - we need Wave.
      Topfuel Topfuel 21 minutes ago
      Wow looks like someone really struck a nerve with their posts. Must have some truth to it for a response like that singling out specific posts and doing a update.

      If that’s not a real sign this company is supporting and feeding themself off this board I don’t know what is.
      DBMM
      Topfuel Topfuel 30 minutes ago
      Oh geez that’s pretty sad when a company has to post this stuff about themselves in stead of staying focused on their growth and what there actually doing to build the business they supposedly participate in.

      Obviously this is cutting into their cash flow dumping shares on new invest
      DBMM
      Just the facts maam Just the facts maam 33 minutes ago
      In 2014, ANIP issued $143.75 million in senior convertible notes due in 2019. ANIP was trading around $53. Conversion price was $69.48 and they took a hedge with a strike price of $96.21. The increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change went to $205.
      ANIP
      frans frans 33 minutes ago
      nicecompany
      LGCB
      frans frans 33 minutes ago
      nicecompany
      LGCB
      diggitydoodle diggitydoodle 35 minutes ago
      It's a new week, and RNVA has put out their late 8k. But, I didn't see a guarantee for a nice payoff to RNVA shareholders from all the seemingly good FOXO news. We don't know what this CEO has planned, and the 8k doesn't spell out anything. Forget what others "read into it". Plans and explanations i
      FOXO RNVA
      Hummingbird2 Hummingbird2 36 minutes ago
      🚀 $TAMG 🚀 - a shareholder communicated with the ceo and said filings and updates are coming.

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175123782

      🚀 $TAMG 🚀
      TAMG
      SidewaysTrader SidewaysTrader 36 minutes ago
      Sitting on support at .001 looks good for entry
      AXXA
      QaB2i QaB2i 38 minutes ago
      Exit time.
      NUKK
      Hummingbird2 Hummingbird2 39 minutes ago
      https://x.com/ldev117/status/1837160516042780867

      $TAMG
      TAMG
      Hummingbird2 Hummingbird2 41 minutes ago
      https://x.com/ldev117/status/1836798460344848885

      $TAMG
      TAMG

      Your Recent History

      NASDAQ
      EVFM
      Evofem Biosciences
      USOTC
      STJPF
      St James Cap (PK)
      Delayed Upgrade Clock